Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT between Vertex Pharmaceuticals Incorporated and...Confidential Treatment Requested • July 2nd, 2004 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
This Agreement is a modification and continuation of a relationship originally set forth in an earlier Cystic Fibrosis Research Alliance and Commercialization Agreement dated as of May 19, 2000 (the “Original Agreement”), between the Cystic Fibrosis Foundation, which is an Affiliate of CFFT, and Aurora Biosciences Corporation, which was acquired by Vertex in 2001. Except as specifically provided herein, this Agreement supercedes in its entirety the Original Agreement which shall be of no further force and effect.
Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission EXCLUSIVE RESEARCH COLLABORATION, LICENSE AND COMMERCIALIZATION AGREEMENT between MERCK & CO., INC. and...Confidential Treatment Requested • July 2nd, 2004 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • New York
This EXCLUSIVE RESEARCH COLLABORATION, LICENSE AND COMMERCIALIZATION AGREEMENT (this “Agreement”) is effective as of June 21, 2004, (the “Effective Date”) and is entered into by and between Merck & Co., Inc., a New Jersey corporation (“Merck”), and Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (“Vertex”).
